Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan OpGen Inc (OPGN)

OpGen, Inc. (OPGN) automates pathogen detection using robotic systems that eliminate human error. The available price action vector based on the EV/EBITDA metric is . OpGen, Inc. (OPGN) relies on the high value of Acuitas tests in clinics where demand remains stable. Production is scaling through partnerships with CDMO contractors, while risks are minimized via strict quality control and long-term agreements.

The multiple compares the total enterprise value, including net debt, to operating profit before depreciation and amortization. This ratio determines the issuer's maturity phase and the stability of its model through the discounting of future cash flows. The weak pricing power of OpGen, Inc. (OPGN) in the molecular diagnostics segment limits EBITDA growth, which is reflected in the EV/EBITDA value over time as a signal of capital impairment risk.